SARS-CoV-2 – whole pathogen molecular controls are now available in Qnostics. The Medium Q Controls (SCV2MQC) are manufactured under ISO standard 13485: 2016 compliant systems. The samples were prepared by making quantitated dilutions of whole SARS-CoV-2 into transport medium. The SARS-CoV-2 viral particles were inactivated by heat treatment and gamma irradiation. Samples are representative of…
Qnostics is attending the 2019 AABB Annual Meeting in San Antonio, TX – Oct 18-22, 2019 If you wish to meet us to discuss your molecular controls requirements, please contact us at info@qnostics.com
Qnostics is attending the 11th European Meeting on Molecular Diagnostics (EMMD) 2019 in Noordwijk, The Netherlands, 09th – 11th October. If you wish to meet us at EMMD 2019 to discuss your molecular controls requirements, please contact us at info@qnostics.com
Qnostics Launches RSV and RV Molecular ‘Q’ Controls Glasgow, United Kingdom, 12th August 2014 – Qnostics Ltd. today announced the addition of another 2 target members to its own brand products. The Qnostics ‘Q’ Control range now includes Respiratory Syncytial virus (RSV) and Rhinovirus (RV), which brings the number of targets in this range to…
Glasgow, United Kingdom, 3rd July, 2014 – Qnostics Ltd. announced today that it has received CE Marked status for its new CMV molecular controls. These products are a welcome addition to the existing range of respiratory and transplant molecular controls. “The launch of the CMV CE Marked molecular controls is a major achievement for Qnostics.…
Glasgow, United Kingdom, 7th January, 2014 – Qnostics Ltd. serving molecular laboratories, today announced it has launched several new molecular controls for use within the testing procedures for a variety of respiratory and transplant assays. “The launch of our new molecular controls allows the company to further strengthen its Transplant range of molecular controls as…